Home
Pre-Filled Syringes and Injectable Drug Devices West Coast
June 9 - June 10, 2025
Pre-Filled Syringes and Injectable Drug Devices West Coast

SAE Media Group’s 9th Annual Conference
Pre-Filled Syringes West Coast
9th - 10th June 2025, CA, USA
-------------------------------------------------------------------------
Foster Innovation and Collaboration at the 9th Annual Pre-Filled Syringes and Injectable Drug Devices West Coast Conference!

Join us in June 2025 as SAE Media Group’s renowned West Coast event returns, bringing together biotech pioneers, pharma leaders, and device innovators to shape the future of injectable drug delivery.

This year’s conference offers an unparalleled platform to explore cutting-edge advances in combination product technology while fostering collaboration between pharma, device developers, and regulators.

Why Attend?

  • Foster Collaboration and Innovation: Engage with industry leaders such as AstraZeneca, Gilead, and Alnylam to explore new opportunities, address challenges like large-volume delivery, and stay informed about emerging technologies.
  • Stay Updated on Global Regulatory Trends: Participate in discussions on evolving EU and US regulations, including the latest digital health technology registration requirements, with insights from Merck.
  • Optimize Combination Product Manufacturing: Learn strategies from leaders like Ionis to enhance combination product manufacturing and effectively manage product lifecycles.
  • Enhance Human Factors Understanding: Gain practical knowledge from JnJ and AbbVie on best practices for human factors, including testing and validation approaches for combination products.

What You’ll Gain:

  • Actionable insights to strengthen your drug-device portfolio.
  • Opportunities to network with key players shaping the injectable drug delivery landscape.
  • A future-focused perspective on innovation, regulation, and patient-centric care.

This must-attend event is your chance to stay ahead in the rapidly evolving injectable drug delivery space. We look forward to welcoming you to the West Coast in June 2025!

FEATURED SPEAKERS

Amin Sedighiamiri

Amin Sedighiamiri

Director, Device Development, AstraZeneca
Christina Rabolli

Christina Rabolli

Principal Engineer, Device Development, Bristol Myers Squibb
Daphne King

Daphne King

Previously Associate Director, Regulatory CMC, Biomarin
EJ Brandreth

EJ Brandreth

Senior VP, Quality, Inovio
James P. Wabby

James P. Wabby

Executive Director, Head of Regulatory Strategy, emerging Technologies and Combination Products, AbbVie
Kevin Zen

Kevin Zen

Senior Director, IGM Biosciences
Mitch  Zhao

Mitch Zhao

Distinguished Engineer, JnJ Innovative Medicine
Phil Estepa

Phil Estepa

Executive Director, Pharmaceutical Development, Ionis Pharmaceuticals
Sheldon Moberg

Sheldon Moberg

Senior VP Drug Delivery, Bexson Biomedical
Wenjing Wang

Wenjing Wang

Associate Principal Scientist in Regulatory Affairs, Merck & Co

Alasdair Young

Senior Director - Device Engineering, Gilead Sciences
Alasdair Young

Alasdair has been with Gilead for approaching two years, leading the development group as part of Device Engineering. Alasdair has spent 18yrs working on combination products for a number of pharma and biotech companies. Over the recent years he has played a pivotal role in the development and approval of a number of combination products spanning prefilled syringes, autoinjectors, and on-body delivery systems. He has also held roles in early concept development and commercial support during his career.

Alasdair holds a Master’s degree in Manufacturing Engineering from Cambridge University and a Bachelor’s degree in Mechanical Engineering from Glasgow University.
 

Amin Sedighiamiri

Director, Device Development, AstraZeneca
Amin Sedighiamiri

Amin Sedighiamiri has a PhD in Mechanical Engineering with more than 12 years of technical leadership experience, including product innovation and commercialization across multiple industry segments, like medical device, combination product, automotive and water management in Europe and the US. Currently, he is Device Development Engineering Manager in Dosage Form Design and Development organization of AstraZeneca where he is leading combination product development as well as smart drug delivery device technology development projects.

Before joining AstraZeneca, Amin worked as Sr. Engineer in Delivery, Device and Connected Solutions Organization of Eli Lilly and Company, where he led cross-functional teams of engineers to develop connected solutions for drug delivery devices.

He is also Board Member and Technical Programming Committee Chair at Medical Plastics Division in Society of Plastics Engineers.
 

Aniket Badkar

Director, Pharmaceutical Product Development, Vir Biotechnology
Aniket Badkar

Christina Rabolli

Principal Engineer, Device Development, Bristol Myers Squibb
Christina Rabolli

Christina Rabolli is a Principal Engineer within the Device Development team at Bristol Myers Squibb, where she has worked on several combination product programs, employing several different types of delivery technologies. Prior to her time at BMS, Christina spent 7 years with BD, contributing to the development of two wearable injector devices and managing relationships with pharmaceutical partners. She also spent time at Pfizer, primarily focused on sustaining engineering activities for on-market prefilled syringe products. Christina has had the enjoyable experiences during her career of working for both a device constituent supplier and a pharmaceutical company, and across the entire combination product lifecycle.

Daphne King

Previously Associate Director, Regulatory CMC, Biomarin
Daphne King

With a robust history of engagement with US, EU, and international regulatory agencies, Daphne King is a seasoned leader in the biopharmaceutical, medical device, combination products, Companion Diagnostics and digital/mobile health sectors. Daphne King possesses extensive expertise in regulatory strategy, Chemistry, Manufacturing and Controls (CMC), submissions, project management, quality systems, and biopharmaceutical regulations, including FDA, EU, and other global regulations.
Demonstrating a thorough understanding of key regulatory frameworks such as FDA 21 CFR 820, ISO 13485, ISO 14971, MDSAP, and MDR/IVDR, Daphne King has been instrumental in driving product development and securing approvals for US, EU, and global commercialization, ensuring alignment with corporate goals and objectives.
Key achievements include:

  • Supporting product development and approval processes across various markets
  • Enhancing regulatory compliance by forming and leading effective cross-functional teams
  • Building productive external alliances with agency reviewers
  • Cultivating effective stakeholder relationships to drive regulatory compliance and project success

As an accomplished director of regulatory affairs, Daphne King combines deep regulatory knowledge with strong leadership and project management skills. Daphne King has a proven track record of managing complex projects from inception to delivery, balancing competing priorities, and leading high-performing teams. Recognized for the ability to build successful relationships with cross-functional teams, FDA, EMA, and other health agency reviewers, Daphne consistently contributes to the achievement of corporate regulatory objectives.

 

EJ Brandreth

Senior VP, Quality, Inovio
EJ Brandreth

E.J. has over 35 years in life sciences including small molecules, devices, and pivotal biotechnology products, and is currently the Head of Quality for Inovio Pharmaceuticals, where he oversees QA for a combination Medical Device and DNA therapeutic platform. He was previously Sr. Vice President of Quality and Regulatory Affairs at Ajinomoto Althea Technologies, specializing in CMO biotech processing and aseptic filling. He was the Sr. Director of Quality for BioMarin where he helped design and build the commercial orphan drug facility and launched Aldurazyme® and Naglazyme®. During the startup of IDEC Pharmaceuticals he held various management positions in QA, Validation and Regulatory Affairs, and was a core team member for the development and launch of Rituxan® and Zevalin®. He is the past Chairman of the PDA Biotech Advisory Board, author of several PDA Technical Reports, UCSD Dean’s Leadership Counsel, and is the past President of ISPE, San Diego. He holds an MBA from UOP and a BA in Biology from UCSD.

James P. Wabby

Executive Director, Head of Regulatory Strategy, emerging Technologies and Combination Products, AbbVie
James P. Wabby

Kevin Zen

Senior Director, IGM Biosciences
Kevin Zen

Kevin has served leadership positions developing therapeutic biological products at AbbVie, AnaptysBio, Catalent Biopharma Solutions, IGM Biosciences, and Opthea. Kevin not only has in-depth expertise in Analytical Development but also has broad experience in Biologics CMC technical operations. In addition to developing therapeutic biological products in-house, Kevin also had extensive experience selecting and managing external CDMO and CRO. He was often invited to present seminars and offer training courses on biologics process development, manufacturing, control strategies, formulation, analytical technology, comparability, process and method validation in the international conferences. In his career, he has successfully managed many biological drug candidates from early development to commercial.

 

Kinsuk Shah

Sr. AD Combination Product Steward, Boehringer Ingelheim
Kinsuk Shah

Mitch Zhao

Distinguished Engineer, JnJ Innovative Medicine
Mitch  Zhao
  • 20 years at JNJ
    • 16 years at JNJ Innovative Medicine as a multi-discipline drug/device combination product development team leader responsible for developing primary containers and drug delivery devices for various programs including guselkumab (Tremfya) and ustekinumab (Stelara)
    • 4 years at JNJ MedTech as technical leader on insulin pump and infusion set development
  • 6 years at two biotech companies in the bay area as team leader on developing microfluidic chips for bioanalytical applications
  • 10 issued patents and ~ 10 pending patents on drug delivery devices and microfluidics;
  • Over 20 peer-reviewed papers with total citations of > 8000
  • Ph.D in Chemistry; B.En and M. En in App. Chem

 

Phil Estepa

Executive Director, Pharmaceutical Development, Ionis Pharmaceuticals
Phil Estepa

Phil is the Executive Director Pharmaceutical Development & Head of Devices at Ionis Pharmaceuticals. Phil has 20 years of experience in combination product R&D, Development and Manufacturing. He has been instrumentally involved in device strategy, delivery innovation, tech transfer-scale up and setting up manufacturing sites domestically and globally.
Prior to Ionis Pharmaceuticals, Phil has worked for Xeris Pharmaceuticals, Kaleo Pharma, Apricus Biosciences, Amylin-Bristol Myers Squib-AstraZeneca Alliance and Medtronic in various roles from Principal Engineer to Executive Leadership in the successful development and commercialization of 11 Combination Products.
Phil holds two issued patents in medical and drug delivery devices and has multiple patent applications. His education includes undergraduate studies Industrial Engineering Technology locally from San Diego State University, with an emphasis in plastics/polymer science. Prior to his life science career, Phil was involved in aerospace engineering in the development of the Apache Helicopter, F-18 Super Hornet, A-12 Avenger, and multiple UAV aircraft used in today’s defense strategy.

 

Renato Ravanello

Sr. Director, Device and Packaging Development, Genentech
Renato Ravanello

Renato Ravanello is responsible for Late Stage Development in the Device and Packaging team at Genentech in South San Francisco, CA. Renato leads the design of new combinations products for clinical and commercial, focusing on new technologies for sub-cutaneous and ocular drug delivery.

Renato has been developing and commercializing combination products and medical devices for over 17 years, and has extensive experience in pre-filled syringes, needle safety devices, injector pens, patch injectors, auto-injectors, ocular drug delivery, and respiratory and transdermal drug delivery devices. He holds an M.S. in Aerospace Engineering from the University of Colorado (Boulder) and a Degree in Aeronautical Engineering from the Politecnico di Milano (Italy).
 

Sheldon Moberg

Senior VP Drug Delivery, Bexson Biomedical
Sheldon Moberg

Sheldon Moberg is the Sr. Vice President of Drug Delivery at Bexson Biomedical where he is responsible for drug delivery systems as part of Bexson's combination product portfolio. He was previously VP Drug Delivery at Amgen where he oversaw drug delivery strategy and development. Prior to Amgen, Sheldon held Research and Development leadership positions at Medtronic's MiniMed managing insulin drug delivery system R&D. Mr. Moberg has over 30 years of experience developing and commercializing innovative medical devices and combination products. He earned a Master's in Mechanical Engineering from Purdue University and a Bachelor's in Mechanical Engineering from California Polytechnic State University, SLO. Sheldon has been awarded 151 US patents, the majority of which are applied to commercialized products.


 

Shiang Gwee

Director, Drug Product Development, Altrubio, Inc.
Shiang Gwee

Wenjing Wang

Associate Principal Scientist in Regulatory Affairs, Merck & Co
Wenjing Wang

Wenjing Wang is a seasoned regulatory affairs expert with over nine years of industry experience in medical devices, combination products and in vitro diagnostic devices. Her latest experience includes regulatory registration for digital health technologies (DHTs) being utilized in decentralized clinical trials and DHTs being part of the combination product. Wenjing has master’s degrees in Biochemistry and Regulatory Affairs and a bachelor’s degree in biotechnology. She has extensive experience in global registrations including FDA, Health Canada, EMA, JMHW, NMPA, and other foreign agencies for various types of medical devices.

sponsors


Senior Director - Device Engineering
Gilead Sciences
Director, Device Development
AstraZeneca
Director, Pharmaceutical Product Development
Vir Biotechnology
Principal Engineer, Device Development
Bristol Myers Squibb
Previously Associate Director, Regulatory CMC
Biomarin
Senior VP, Quality
Inovio
Executive Director, Head of Regulatory Strategy, emerging Technologies and Combination Products
AbbVie
Senior Director
IGM Biosciences
Sr. AD Combination Product Steward
Boehringer Ingelheim
Distinguished Engineer
JnJ Innovative Medicine
Executive Director, Pharmaceutical Development
Ionis Pharmaceuticals
Sr. Director, Device and Packaging Development
Genentech
Senior VP Drug Delivery
Bexson Biomedical
Director, Drug Product Development
Altrubio, Inc.
Associate Principal Scientist in Regulatory Affairs
Merck & Co

Gold Sponsors

Sponsors

Exhibitors

VENUE

San Diego Marriott La Jolla

4240 La Jolla Village Drive, La Jolla , San Diego, California , USA

A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
HOTEL BOOKING FORM

Past Attendee List

Download

Sponsors and Exhibitors


SHL Medical

Gold Sponsors
http://www.shl-medical.com

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Driven by our purpose of “enabling patients’ independence”, we partner with leading pharma and biotech companies to develop self-injection systems and digital solutions that enhance patients’ treatment experience and quality of life. Our customers benefit from our proven track record and scalable, global manufacturing excellence, with locations in Switzerland, USA, Sweden, and Taiwan. By focusing on innovation, we challenge the status quo and shape the future of state-of-the-art drug delivery. We cover the entire drug delivery value chain, providing piece of mind through our end-to-end services, from design, development, to final assembly, labeling, and packaging.


Suttons Creek

Gold Sponsors
http://www.suttonscreek.com

Suttons Creek is pharma’s device team. Any company adopting combination product technology needs an experienced combination products team working alongside their drug team, including specialists in areas like quality, regulatory, vendor selection and management, systems engineering, risk management, clinical development, and commercialization. Suttons Creek has over 650 years of combined experience and 120+ combination product projects under its belt, with a talent pool of subject matter experts that specialize in all aspects of combination product development from strategic planning through device development to launch and postmarket activities. We can be any or all things combination product to a client, consulting hour by hour or engaging in strategic partnerships to achieve milestones, lift roadblocks, fill knowledge gaps, and drive program success.


Sponsors


Credence MedSystems

Sponsors
http://www.credencemed.com

Credence MedSystems is an innovator in injectable drug delivery devices. Credence’s philosophy of Innovation Without Change results in products that impress and protect end-users while preserving pharma’s existing processes, sourcing strategies and preferred primary package components. The Companion® family of syringe systems includes proprietary needle-retraction technology, reuse prevention and other critical safety and usability features in Staked and Luer needle formats. The Dual Chamber platform offers single-step mixing and injection for drugs requiring reconstitution at the time of delivery. Additional products such as metered dose devices, multi-length staked needles and other novel devices address the needs of specific therapeutic markets.


Datwyler

Sponsors
https://healthcare.datwyler.com/

Datwyler provides high-quality, system-critical elastomer components and has a leading position in the global healthcare market. Within the healthcare solutions business area, Datwyler develops, designs, and manufactures solutions for injectable packaging and drug delivery systems to facilitate customers to create a safer medical environment of tomorrow. Looking back onto more than 100 years of history, Datwyler is a reliable partner, now and in the future!


EdgeOne Medical

Sponsors
http://www.edgeonemedical.com/

EdgeOne Medical is a leading global Contract Device Development Organization, serving as the trusted testing and device development partner for 11 of the top 20 global pharmaceutical companies. As experts in compliant device development from benchtop to commercialization, we leverage our extensive industry knowledge, advanced in-house laboratory, and ISO 13485 certified Quality Management System to accelerate and derisk the development journey for our clients. EdgeOne Medical’s ability to get it “Right First Time” has made us the preferred partner for many key players in emerging pharma and big pharma. Our track record includes supporting the device development programs of newly acquired emerging pharmaceutical companies such as Carmot, Chinook, Dicerna, Horizon Therapeutics, and cell therapy innovator Miromatrix.



Haselmeier

Sponsors
https://haselmeier.com/en/

o Haselmeier, the drug delivery device business of medmix, designs, develops and manufactures advanced drug delivery systems such as pen injection systems and autoinjectors. Patient comfort and customers’ needs are always at the heart of the company’s practices. With its broad portfolio of technologies and services, Haselmeier delivers user-friendly injection systems that enable patients to self-administer their medication reliably and accurately. Haselmeier is known for its excellent and long-standing track record in providing these innovative drug delivery devices based on its proprietary IP business model. The company collaborates closely with its customers in the pharmaceutical and biopharmaceutical industries. Medmix, with its precision injection molding capabilities and expertise in liquid micro-dosing plus financial strength and global footprint, helps Haselmeier accelerate innovation in healthcare. With more than 100 years of expertise in the development and manufacture of drug delivery devices, our global footprint, nearly 250 distinguished and motivated experts, more than 200 patents granted, and numerous patents pending, Haselmeier remains committed to developing innovative solutions that support our customers and help improve the health of millions of people worldwide.



Mitsubishi Gas Chemical

Sponsors
https://www.mgc.co.jp/eng/products/abd/oxycapt.html

Mitsubishi Gas Chemical is a leading company in the field of oxygen barrier and absorbing technologies. Based on these technologies and experiences, we have successfully developed multilayer plastic vial and syringe having excellent oxygen, ultra violet and water vapor barrier. The products make it possible to replace glass with plastic for injectable drugs.


ZEON

Sponsors
https://www.zeon.eu/

o ZEON’s Zeonex® and Zeonor® cyclo olefin polymer (COP) allow for advanced, break-resistant syringes, vials and lyophilization containers for protein-based biopharmaceuticals, high viscosity drugs, and contrast media. They also offer high purity, “glass-like” transparency, sterilization, low water absorption, and superior moldability, as well as overcome protein adsorption and ph shift concerns. Please visit our booth and discover why COP is an excellent choice for drug storage and pre filled syringes.


Exhibitors


Gerresheimer

Exhibitors
http://www.gerresheimer.com

Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The company offers a comprehensive portfolio of pharmaceutical primary packaging, drug delivery systems and digital solutions. Gerresheimer ensures that medicines reach patients safely and can be administered reliably. With around 12,000 employees and 35 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for the regional markets with a focus on the pharma industry.



Nipro PharmaPackaging

Exhibitors
http://www.nipro-group.com

Nipro PharmaPackaging is specialized in developing and manufacturing advanced pharma packaging products and complete packaging solutions for early development drugs or the enhancement of packaging solutions for existing drugs. With a worldwide manufacturing footprint of 19 plants, multiple sales offices, and lab services, Nipro offers an exceptional service platform. Through our personnel, products, and services, Nipro PharmaPackaging enables you to provide a safer and healthier administration to your customers. Nipro PharmaPackaging is part of Nipro Corporation Japan, established in 1954. As a leading global healthcare company with over 35,000 employees worldwide, Nipro serves the Pharmaceutical, Medical Device, and Pharmaceutical Packaging industries.


Owen Mumford

Exhibitors
http://www.owenmumford.com

Owen Mumford Pharmaceutical Services is a specialist in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech & generics industries. These include single dose and multidose reusable and disposable auto-injectors, pens and syringes for subcutaneous and intramuscular administration. Our innovative products are designed to meet both the need of our pharmaceutical partners and their patients by facilitating ease of use and improving safety and patient compliance. Our devices are also designed with aim of reducing complexity and risk for the pharmaceutical & biotech industry in the development of their combination products.

For more information please visit https://www.ompharmaservices.com/



Terumo

Exhibitors
https://www.terumopharmaceuticalsolutions.com/en-EMEA

As Part of Terumo Medical Care Solutions, the Pharmaceutical Solutions Division develops patient-oriented parenteral delivery solutions for therapeutic performance and safety.

Globally trusted for quality and precision, we offer pharmaceutical and medical device manufacturers around the world comprehensive product design and development services.

We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral drug delivery.

Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies, including CDMO services for all parenteral applications.

We listen. We question. We deliver.


SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

San Diego Marriott La Jolla

4240 La Jolla Village Drive
La Jolla
San Diego 92037
USA

San Diego Marriott La Jolla

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download

Title


Description

Download

Title


Description


Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

Group Booking

Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SAE Media Group

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smgconferences.com Email: events@saemediagroup.com
Registered in England - SMi Group Ltd trading as SAE Media Group




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SAE Media Group.
Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

Fill in your details to download the brochure

By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.